サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451760

ウィメンズヘルス市場レポート：年齢層別、用途別、流通チャネル別、地域別、2024-2032

Women's Health Market Report by Age Group Type, Application, Distribution Channel, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=141.77円
ウィメンズヘルス市場レポート：年齢層別、用途別、流通チャネル別、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のウィメンズヘルス市場規模は2023年に410億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて3.78%の成長率（CAGR）を示し、2032年までに579億米ドルに達すると予測しています。高齢女性の人口増加、加齢に伴う特有の健康ニーズ、ウィメンズヘルスに対する社会的規範や態度の変化、ヘルスケアサービスへのアクセス向上のための資金調達の増加は、市場を推進する主な要因の一部です。

ウィメンズヘルスとは、女性の身体的・精神的な幸福に影響を与える病気や状態の治療と診断に焦点を当てた医学の一分野を指します。リプロダクティブ・ヘルス、妊産婦の健康、メンタルヘルス、非伝染性疾患など、幅広い専門分野と重点分野を包含しており、これらはすべて女性に大きな影響を与える可能性があります。それは女性個人の幸福のために不可欠であるだけでなく、経済的生産性、家族の安定、公衆衛生の結果に関連する、より広い社会的意味合いも持っています。さらに、これらの問題は、生物学的要因だけでなく、社会規範、ライフスタイルの選択、ヘルスケアへのアクセスにおける性差にも影響されることに注意することが重要です。したがって、ウィメンズヘルスに対する包括的なアプローチには、これらの多面的な側面を理解し、それに取り組むことが必要です。

女性の高齢化は、ウィメンズヘルス市場の重要な促進要因です。女性は年齢を重ねるにつれ、更年期障害、骨粗鬆症、心臓病、ある種のがんなど、特有の健康課題に直面するようになります。このように世界的に高齢女性の人口が増加し、加齢に伴う特有の健康ニーズが、サービスや製品に対する旺盛な需要を生み出しています。これとともに、ウィメンズヘルスに対する社会の規範や考え方の変化も、この業界の重要な推進力となっています。そのため、性別に特化したヘルスケアの権利と必要性が認識されるようになり、市場にプラスの影響を与えています。さらに、世界全体のヘルスケア支出の増加も、ウィメンズヘルス市場の成長に大きく寄与しています。所得水準が上がるにつれて、個人や家族は予防医療や治療医療に投資する傾向が強くなっています。政府もまた、予算の多くをヘルスケアに充てるようになっています。このような促進された資金により、ヘルスケア・サービスへのアクセスが向上し、女性用ヘルスケアの研究や製品開発の進歩が促進されています。

ウィメンズヘルス市場の動向と促進要因：

意識の高まりと政府の取り組み

過去数年間、世界各国の政府、非営利団体、国際機関は、ウィメンズヘルス問題に対する認識を高める上で重要な役割を果たしてきました。これは主に、キャンペーン、政策変更、調査やサービスへの資金提供を通じて達成されてきました。このような取り組みにより、健康問題が世界的に注目される環境が醸成され、女性用健康商品やサービスに対する需要の増加につながった。さらに、こうした政府の取り組みには、健康診断、診断テスト、予防措置に関する規定が含まれていることが多く、これが業界の成長をさらに後押ししています。例えば、様々な政府の法律では、健康保険による予防サービスの提供が義務付けられており、このようなサービスに対する需要を増幅させています。

技術の絶え間ない進歩

技術の急速な進歩は、ウィメンズヘルス産業に大きな影響を与えています。これに伴い、診断ツールや治療法も進化・改善し、より良い病気の発見、より効果的な治療、生存率の向上につながっています。テレヘルス、モバイルアプリ、ウェアラブルデバイスなどのデジタルヘルス技術は、現在、ウィメンズヘルス状態をより効率的に追跡・管理するのに役立っています。人工知能や機械学習を含む先進技術も、様々な関連問題の診断や治療に採用されています。こうした技術の進歩は、女性にとってより効果的で個別化されたヘルスケアソリューションを保証するだけでなく、新たな機会と需要を生み出すことで市場の成長を刺激します。

慢性疾患の増加

がん（特に乳がんや子宮頸がん）、心血管疾患、糖尿病、骨粗しょう症など、女性の慢性疾患罹患率の増加が、こうしたサービスの必要性を高めています。世界保健機関によると、非伝染性疾患、特にがんや心血管疾患は、世界中の女性の死因の大半を占めています。これと相まって、女性の慢性疾患の憂慮すべき増加は、タイムリーな発見、効果的な治療オプション、予防ケアの増加を必要とし、これらはウィメンズヘルス産業の主要な推進力となっています。また、リプロダクティブ・ヘルスは依然として市場の重要な側面です。この業界では、妊産婦死亡率や乳児死亡率を下げるために、家族計画サービスや出産前ケア、安全な出産方法へのアクセスが重視されるようになっており、市場にさらなる影響を与えています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のウィメンズヘルス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：年齢層別

  • 50歳以上
    • 市場動向
    • 主要セグメント
      • 閉経後骨粗鬆症
      • 子宮内膜症および子宮筋腫
      • 更年期障害
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 避妊薬
    • 市場動向
    • 市場予測
  • 骨粗鬆症
    • 市場動向
    • 市場予測
  • 更年期障害
    • 市場動向
    • 市場予測
  • 不妊症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • AbbVie Inc.
    • Agile Therapeutics Inc.
    • Amgen Inc.
    • Bayer AG
    • F. Hoffmann-La Roche AG
    • Ferring Pharmaceuticals
    • FUJIFILM Holdings Corporation
    • Hologic Inc.
    • Lupin Limited
    • Novo Nordisk A/S
    • Pfizer Inc.
図表

List of Figures

  • Figure 1: Global: Women's Health Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Women's Health Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Women's Health Market: Breakup by Age Group (in %), 2023
  • Figure 5: Global: Women's Health Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Women's Health Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Women's Health Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Women's Health (50 Years and Above) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Women's Health (50 Years and Above) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Women's Health (Other Age Groups) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Women's Health (Other Age Groups) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Women's Health (Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Women's Health (Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Women's Health (Osteoporosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Women's Health (Osteoporosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Women's Health (Menopause) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Women's Health (Menopause) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Women's Health (Infertility) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Women's Health (Infertility) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Women's Health (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Women's Health (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Women's Health (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Women's Health (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Women's Health (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Women's Health (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Women's Health (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Women's Health (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Women's Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Women's Health Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Women's Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Women's Health Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Women's Health Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Women's Health Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 3: Global: Women's Health Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Women's Health Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Women's Health Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Women's Health Market: Competitive Structure
  • Table 7: Global: Women's Health Market: Key Players
目次
Product Code: SR112024A7615

The global women's health market size reached US$ 41.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3.78% during 2024-2032. The growing population of elderly women, and the specific health needs associated with aging, changing societal norms and attitudes towards women's health, and the rising funding for better access to healthcare services are some of the major factors propelling the market.

Women's health refers to the branch of medicine that focuses on the treatment and diagnosis of diseases and conditions that affect a woman's physical and emotional well-being. It encompasses a broad range of specialties and focus areas, such as reproductive health, maternal health, mental health, and non-communicable diseases, which can all significantly impact women. It is vital not only for the individual well-being of women, but it also has wider societal implications relating to economic productivity, family stability, and public health outcomes. Furthermore, it's important to note that these issues are influenced by biological factors as well as gender-related differences in societal norms, lifestyle choices, and access to healthcare. Thus, a comprehensive approach to women's health necessitates understanding and addressing these multifaceted dimensions.

The aging female population is a key driver of the women's health market. As women age, they face a specific set of health challenges including menopause, osteoporosis, heart disease, and certain types of cancer. This increasing population of elderly women globally, and the specific health needs associated with aging, create a robust demand for services and products. Along with this, changing societal norms and attitudes towards women's health have also acted as a significant driver in this industry. Therefore, the growing recognition of rights and the need for gender-specific healthcare is positively influencing the market. In addition, the rise in healthcare spending across the globe also contributes significantly to the growth of the women's health market. With higher income levels, individuals and families are more inclined to invest in preventive and curative healthcare. Governments, too, are dedicating larger portions of their budgets towards healthcare. This accelerated funding allows for better access to healthcare services and promotes advancements in women's healthcare research and product development.

Women's Health Market Trends/Drivers:

Increased Awareness and Government Initiatives

Over the past few years, governments across the globe, non-profit organizations, and international agencies have played an instrumental role in heightening awareness about women's health issues. This has been primarily achieved through campaigns, policy changes, and funding for research and services. These initiatives have fostered an environment where health matters are gaining global attention, leading to increased demand for women's health products and services. Moreover, these government initiatives often include provisions for health screenings, diagnostic tests, and preventive measures, which further drive the growth of the industry. Various government acts, for instance, make preventative services for a mandatory health insurance provision, amplifying the demand for such services.

Continuous Advancements in Technology

The rapid advancement in technology has significantly impacted the women's health industry. Along with this, diagnostic tools and therapies have evolved and improved, which have led to better disease detection, more effective treatments, and increased survival rates. Digital health technologies, such as telehealth, mobile apps, and wearable devices are now assisting women in tracking and managing their health more efficiently. Advanced technologies, including artificial intelligence and machine learning, are also being employed in the diagnosis and treatment of various related issues. These technological advancements ensure more effective and personalized healthcare solutions for women but also stimulate the market's growth by creating new opportunities and demands.

Rising Incidences of Chronic Diseases

An increasing incidence of chronic diseases among women, such as cancer (specifically breast and cervical cancer), cardiovascular diseases, diabetes, and osteoporosis, is driving the need for these services. According to global health organizations, non-communicable diseases, notably cancer, and cardiovascular diseases, are responsible for the majority of deaths among women across the globe. In confluence with this, this alarming rise in chronic conditions among women necessitates timely detection, effective treatment options, and increased preventive care, which are the major propellers for the women's health industry. Also, reproductive health remains a significant aspect of the market. The industry is witnessing a growing emphasis on access to family planning services, prenatal care, and safe childbirth practices to reduce maternal and infant mortality rates, further impacting the market.

Women's Health Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global women's health market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on age group type, application and distribution channel.

Breakup by Age Group Type:

50 Years and Above

Postmenopausal Osteoporosis

Endometriosis and Uterine Fibroids

Menopause

Others

50 Years and Above dominate the market

The report has provided a detailed breakup and analysis of the market based on the age group type. This includes 50 years and above (postmenopausal osteoporosis, endometriosis and uterine fibroids, and menopause), and others. According to the report, 50 years and above represented the largest segment.

The 50 years and above age group in the industry has witnessed significant market drivers over the past decades. One of the primary factors contributing to this trend is the global demographic shift towards an aging population, leading to an increased number of women entering this age bracket. Additionally, advancements in healthcare technology and increased access to medical services have enabled better diagnoses and treatments for age-related health conditions in women. In addition, the growing awareness among this demographic regarding preventive healthcare measures and wellness has influenced the demand for specialized products and services catering to their unique needs. As women in this age group seek to maintain their health and quality of life, there is an escalating demand for menopause-related treatments, bone health supplements, and preventive screenings. This market segment's potential for growth is further bolstered by the expanding focus on research, allowing the industry to offer targeted and evidence-based solutions.

Breakup by Application:

Contraceptives

Osteoporosis

Menopause

Infertility

Others

Contraceptives dominate the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes contraceptives, osteoporosis, menopause, infertility, and others. According to the report, contraceptives represented the largest segment.

The industry has been significantly influenced by the increasing global awareness of family planning and reproductive health. Governments, organizations, and healthcare providers are emphasizing the importance of safe and effective contraceptive methods to empower women to make informed choices about their reproductive health. Additionally, advancements in medical technology have led to the development of a wide range of contraceptive options, offering women more choices and personalized solutions to suit their preferences and needs. In confluence with this, the shifting societal attitudes towards women's rights and gender equality have resulted in greater access to contraceptive products and services, enabling women to take control of their reproductive decisions. Furthermore, the growing prevalence of sexually transmitted infections has reinforced the importance of using contraceptives as a means of protection.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Hospital pharmacies dominate the market

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

The hospital pharmacies distribution channel in the industry is experiencing significant market drivers that shape its growth and development. One of the key factors contributing to the prominence of this distribution channel is the rising demand for specialized women's health medications and treatments within hospital settings. Hospitals serve as essential centers for comprehensive medical care, making them an ideal platform to provide a wide range of women's health products, including contraceptives, hormone therapies, fertility medications, and prenatal supplements. Additionally, the increasing prevalence of chronic conditions, such as gynecological disorders and menopause-related symptoms, has led to a growing need for prompt access to medications and treatments, which hospital pharmacies can efficiently cater to. Furthermore, regulatory initiatives and healthcare policies that encourage hospitals to maintain well-stocked pharmacies with a focus on women's health contribute to the expansion of this distribution channel.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The industry in North America is influenced by the region's aging population. It contributes to an increased demand for women's health services and products catering to menopausal and post-menopausal women. Additionally, the growing awareness and emphasis on preventive healthcare measures among women drive the market for screenings, wellness programs, and specialized treatments. In addition, advancements in medical research and technology facilitate the development of innovative solutions, encouraging investment and competition in the industry.

Moreover, favorable healthcare policies and insurance coverage for women's health services bolster market growth. Apart from this, shifting cultural attitudes towards women's empowerment and gender equality enhances access to comprehensive healthcare, including family planning and contraceptive options. Furthermore, strategic marketing efforts and educational campaigns by industry players to promote health and wellness further fuel market expansion.

Competitive Landscape:

The global women's health market is experiencing significant growth due to the growing investments in research and development to create new and improved women's health products, including contraceptives, fertility treatments, hormone therapies, prenatal vitamins, and other related medications. Along with this, companies are promoting their women's health products and services through marketing campaigns to grow awareness among healthcare providers and consumers. These campaigns often focus on promoting the benefits and efficacy of their offerings. Numerous companies are forming partnerships with healthcare providers, clinics, hospitals, and other organizations to expand their market reach and enhance distribution channels, impacting the market. Moreover, the introduction of educational programs for healthcare professionals to ensure proper understanding and usage of their products is contributing to the market.

The report has provided a comprehensive analysis of the competitive landscape in the global women's health market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

AbbVie Inc.

Agile Therapeutics Inc.

Amgen Inc.

Bayer AG

Hoffmann-La Roche AG

Ferring Pharmaceuticals

FUJIFILM Holdings Corporation

Hologic Inc.

Lupin Limited

Novo Nordisk A/S

Pfizer Inc.

Recent Developments:

In June 2023, AbbVie Inc. revealed the names of the 20 amazing women business owners who will receive grants and mentoring from the IFundWomen and BOTOX(R) Cosmetic award programme.

In October 2021, Abbott Laboratories stated that it has signed a three-year contract to serve as the Real Madrid Football Club's Global Health Sciences and Nutrition Partner and Global Partner of the Real Madrid Foundation, whose mission is to spread the ideals of sport to adolescents all over the world. In addition to providing nutritional assistance for the inaugural men's and women's Academy teams as well as new product development, the alliance will also benefit at-risk youngsters in 80 countries via educational, sporting, and social welfare initiatives.

In June 2023, Agile Therapeutics Inc. stated that MMCAP Infuse Members would have access to the Twirla (levonorgestrel and ethinyl estradiol) transdermal system. The business anticipates that this improved supply will have a favorable effect on demand growth and factory sales in the non-retail channel, which climbed 20% and 15%, respectively, from the fourth quarter of 2022 to the first quarter of 2023.

Key Questions Answered in This Report:

  • How has the global women's health market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global women's health market?
  • What is the impact of each driver, restraint, and opportunity on the global women's health market?
  • What are the key regional markets?
  • Which countries represent the most attractive women's health market?
  • What is the breakup of the market based on the age group?
  • Which is the most attractive age group in the women's health market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the women's health market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the women's health market?
  • What is the competitive structure of the global women's health market?
  • Who are the key players/companies in the global women's health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Age Group

  • 6.1 50 Years and Above
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Postmenopausal Osteoporosis
      • 6.1.2.2 Endometriosis and Uterine Fibroids
      • 6.1.2.3 Menopause
    • 6.1.3 Market Forecast
  • 6.2 Others
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Contraceptives
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Osteoporosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Menopause
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Infertility
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agile Therapeutics Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Amgen Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bayer AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Ferring Pharmaceuticals
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 FUJIFILM Holdings Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Hologic Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Lupin Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Novo Nordisk A/S
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Pfizer Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.